REMEDIUM LIFECARE LIMITED Share Target 2024, 2025 To 2039
|
REMEDIUM LIFECARE LIMITED |
|||
|
Price: ₹5.06 | ||
| 52 Week Low: ₹4.94 52 Week High: ₹728.00 |
|||
| Market Capital: N/A | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: REMEDIUM LIFECARE LIMITED Share Price Target For 2024
- 1.1.1: REMEDIUM LIFECARE LIMITED Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: REMEDIUM LIFECARE LIMITED Share Price Target For 2025
- 1.2.1: REMEDIUM LIFECARE LIMITED Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
To predict the REMEDIUM LIFECARE LIMITED's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
REMEDIUM LIFECARE LIMITED Share Price Target For 2024
The line chart displays the monthly closing prices of REMEDIUM LIFECARE LIMITED with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for REMEDIUM LIFECARE LIMITED shares in 2024, see the table below.
REMEDIUM LIFECARE LIMITED Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 5.37 (+6.12%) | Price Action: 12 Dec 2024 High |
| 2024 Target 2 | 5.28 (+4.34%) | Price Action: 18 Dec 2024 Low |
| 2024 Target 1 | 5.22 (+3.16%) | Price Action: 26 Dec 2024 High |
| Current Price | 5.06 | REMEDIUM LIFECARE LIMITED's share price as of 26 Dec 2024 |
| Stop Loss 1 | 4.99 (-1.39%) | Price Action: 26 Dec 2024 Low |
| Stop Loss 2 | 4.94 (-2.38%) | Price Action: Dec 2024 Low |
| Stop Loss 3 | 4.85 (-4.16%) | Price Action: Chart |
Short-Term Technical Outlook
Current Technical Position: REMEDIUM LIFECARE LIMITED is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 25-day moving average at ₹5.48 serves as the nearest technical reference point.
Historical Returns: 3-month: -43.34% | 6-month: -66.33% | 1-year: -98.99%
REMEDIUM LIFECARE LIMITED Share Price Target For 2025
The line chart displays the monthly closing prices of REMEDIUM LIFECARE LIMITED with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for REMEDIUM LIFECARE LIMITED shares in 2025, see the table below.
REMEDIUM LIFECARE LIMITED Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 456.1 (+8,913.83%) | Price Action: 29 Jan 2024 Low |
| 2025 Target 2 | 448.0 (+8,753.75%) | Price Action: 12 Feb 2024 Low |
| 2025 Target 1 | 442.9 (+8,652.95%) | Price Action: 01 Dec 2023 High |
| Current Price | 5.06 | REMEDIUM LIFECARE LIMITED's share price as of 26 Dec 2024 |
| Stop Loss 1 | -109.22 (-2,258.5%) | Price Action: Chart |
| Stop Loss 2 | -108.13 (-2,236.96%) | Price Action: Chart |
| Stop Loss 3 | -106.18 (-2,198.42%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: REMEDIUM LIFECARE LIMITED is currently trading near its 52-week low of ₹4.94, indicating potential value opportunity.
Long-Term Trend Analysis: The stock is in a bearish long-term trend, trading below key long-term moving averages.
Long-Term Performance: 1-year: -98.99% | 3-year: -96.36% | 5-year: NA
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
